BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 31, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for April 16, 2025

April 16, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocon, Boehringer, Catalent, Cellino, Cue Biopharma, Daiichi Sankyo, Invo Fertility, Karis, Lisata, Mural Oncology, Naya, Norgine, Oak Hill, Roche, Regeneron, Rege Nephro, Statera, Syros, Theravia, Tivic Health Systems, Wayfinder.
Read More

Other news to note for April 16, 2025

April 16, 2025
Additional early-stage research and drug discovery news in brief, from: Eleva, NLS Pharmaceutics, Rein Therapeutics, Skye Bioscience.
Read More

Other news to note for April 15, 2025

April 15, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bristol Myers Squibb, Illumina, Imperative, Optellum, Nanowear, Satio, Tempus.
Read More

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accord, Amgen, Coherus, Intas, Kinnate, Sandoz, Sumitomo, Third Harmonic, Xoma Royalty.
Read More

Other news to note for April 15, 2025

April 15, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Evenus, Fresenius Kabi, Hengrui, Kalvista, Kaken, Oncozenge, Opthea, Pacira.
Read More

Other news to note for April 14, 2025

April 14, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Carmat, Elutia, Sequana Medical, Vicarious Surgical.
Read More

Other news to note for April 14, 2025

April 14, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avernus, Opthea, Oncozenge.
Read More

Other news to note for April 11, 2025

April 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Basel Medical Group, Biosymetrics, Bethesda Medical, Cagent Vascular, Daxor, Green Earth Biomedical, Keensight Capital, Motion Informatics, Niox.
Read More

Other news to note for April 11, 2025

April 11, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atossa, Keros, Nona, Revive, Tempest, Tevogen, Torpedo.
Read More

Other news to note for April 10, 2025

April 10, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chemeleon, Drummond, GE Healthcare, Innoblative, Nextech, Ocuco, Ondine, Prapela.
Read More
Previous 1 2 … 59 60 61 62 63 64 65 66 67 … 1403 1404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 30, 2026.
  • Illustration of dopamine signaling in the brain

    New schizophrenia targets challenge trial design

    BioWorld
    The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 28, 2026
  • HIV virus

    AIDS 2026: New targets for metabolic dysfunction despite ART

    BioWorld
    Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
  • Lee-Cheng Liu, chairman, Taiwan BIO

    Taiwan biotech looks outward in next phase of growth

    BioWorld
    Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing